Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
SDGR | Schrodinger, Inc. | Sender Gary | Director | Mar 08, 2021 | Option Exercise | $38.55 | 57,550 | 2,218,317 | 28,775 | Mar 10, 2021, 06:18 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Feb 28, 2021 | Option Exercise | $2.39 | 31 | 74 | 20,472 | Mar 02, 2021, 07:43 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Jan 31, 2021 | Option Exercise | $2.62 | 37 | 97 | 20,503 | Feb 02, 2021, 08:01 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Dec 31, 2020 | Option Exercise | $2.42 | 32 | 77 | 20,540 | Jan 05, 2021, 05:16 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Nov 30, 2020 | Option Exercise | $0.43 | 312 | 133 | 205,728 | Dec 01, 2020, 08:22 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Oct 31, 2020 | Option Exercise | $0.50 | 312 | 155 | 206,040 | Nov 02, 2020, 07:07 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Sep 30, 2020 | Option Exercise | $0.53 | 312 | 166 | 206,352 | Oct 01, 2020, 04:32 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Aug 31, 2020 | Option Exercise | $0.62 | 312 | 193 | 206,664 | Sep 02, 2020, 05:16 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Aug 20, 2020 | Option Exercise | $0.65 | 3,204 | 2,075 | 206,976 | Aug 21, 2020, 07:02 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Jul 31, 2020 | Option Exercise | $0.76 | 312 | 237 | 198,930 | Aug 04, 2020, 04:07 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Jun 30, 2020 | Option Exercise | $0.67 | 312 | 210 | 199,242 | Jul 02, 2020, 04:06 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | May 31, 2020 | Option Exercise | $1.14 | 312 | 356 | 199,554 | Jun 03, 2020, 06:08 AM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Apr 30, 2020 | Option Exercise | $0.55 | 301 | 165 | 193,679 | May 04, 2020, 06:32 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Mar 31, 2020 | Option Exercise | $0.57 | 301 | 173 | 193,980 | Apr 02, 2020, 05:49 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Feb 28, 2020 | Option Exercise | $1.35 | 301 | 406 | 194,281 | Mar 03, 2020, 09:32 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Jan 31, 2020 | Option Exercise | $1.35 | 4,295 | 5,798 | 78,669 | Feb 04, 2020, 08:56 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Aug 21, 2019 | Sale | $2.08 | 3,390 | 7,051 | 19,214 | Aug 26, 2019, 09:35 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Aug 21, 2019 | Option Exercise | $2.08 | 3,390 | 7,051 | 19,214 | Aug 21, 2019, 09:22 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | May 23, 2018 | Buy | $4.57 | 2,000 | 9,140 | 6,200 | May 23, 2018, 08:38 PM | |
NBRV | Nabriva Therapeutics plc | Sender Gary | Chief Financial Officer | Sep 22, 2017 | Buy | $8.21 | 2,000 | 16,420 | 4,200 | Sep 26, 2017, 05:01 PM |